Patent Granted

The patent was granted by the relevant patent office.

The patent covers a new method of use for Certepetide in treating pancreatic cancer and other solid tumors.

The patent covers the company's noninvasive lung cancer detection technology.

The patent was announced via a 6-K filing on September 30, 2026.

Company advances in wearable technology innovation.

The patent covers a system, method, and unit to scan communication channels.

The patent is for a noninvasive lung cancer diagnostic.